| 摘要 |
FIELD: medicine.SUBSTANCE: present group of inventions refers to endocrinology, and concerns preventing hypoglycaemia during type 2 of diabetes mellitus. That is ensured by administration of desProEkzendin-4(1-39)-Lys-NH(AVE0010) preparation or its pharmaceutically acceptable salt in combination with sulphonylurea preparation.EFFECT: such complex administration provides effective prevention of hypoglycemia.18 cl, 10 dwg, 33 tbl, 1 ex |
